2017-06-05 18:50:06 UTC

2017 Freston Preview: Translation and Disease Relevance

June 6, 2017

Learn about sessions three and four of the 2017 Freston conference taking place in St. Paul, MN this September.

Continuing with our preview of the 2017 James W. Freston conference, this week we'll take a look at sessions three and four, which cover the relevance of extracellular vesicles (EVs) in GI diseases.

We've already previewed sessions one and two of the conference, which takes place Sept. 9 and 10, in St. Paul, MN.

Translation: Disease Relevance
Sessions three and four aim to provide greater insight on what research findings have uncovered regarding the role of EVs in GI diseases. During these sessions, you'll hear from prominent researchers:

  • Gregory Gores, MD, AGAF, will report on how hepatocyte injury induce the release of EVs and if the EVs released by stressed hepatocytes mediate inflammation.
  • Gyongyi Szabo, MD, PhD, AGAF, will examine the role of EVs in intercellular communication, the content of circulating EVs in liver disease and the potential mechanism by which EVs modulate target cells.
  • John Bienenstock, MD, FRCP, will explore how gut bacteria may communicate with the enteric nervous system and the brain, and how recent studies of microvesicles (MVs) and outer membrane vesicles (OVMs) define the pathways involved. Dr. Bienenstock will also examine if the characterization of MV and OMV cargo further improves our knowledge of bacterial function.
  • Robert Freishtat, MD, MPH, will present findings on how adipocyte-derived EVs change with increased adiposity, affect glucose regulation and change with decreasing adiposity.
  • Alissa Weaver, MD, PhD, will examine to what extent EVs regulate directional cell migration.

Stay tuned to AGA eDigest and the AGA website for details on sessions five and six. To learn more about the conference and to register, visit the conference web page. Early registration ends Wednesday, June 14.

Funded by the Takeda Endowment in support of the James W. Freston Single Topic Conference.

More on Continuing Education

Advancing Collaborative Approaches in IBD Treatment Decision-Making

March 14, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Advancing Collaborative Approaches in IBD Treatment Decision-Making

Jan. 9, 2018

This is a unique opportunity for payers and providers to gather in the same room to discuss IBD therapy selection, disease monitoring, treatment criteria and access.

Win Free AGA Postgraduate Course Registration

Dec. 7, 2017

It takes less than five minutes to participate in the contest, which could save you up to $480.